June 2019

Scholar Rock Announces Positive Final Results from Phase 1 Clinical Trial of SRK-015 in Healthy Volunteers

Leave a Comment / Clinical Trials, Front Page News, Research /

Scholar Rock today announced positive final top-line results from the Phase 1 clinical trial of its product candidate, SRK-015, a highly specific inhibitor of myostatin activation, in healthy adult volunteers. Consistent with previously announced interim findings, the final results showed robust and sustained target engagement and no apparent safety signals were observed across all tested […]

Scholar Rock Announces Positive Final Results from Phase 1 Clinical Trial of SRK-015 in Healthy Volunteers Read More »

Cure SMA to Host “Evening in the Park” at Disneyland Thanks to Support from AveXis

Leave a Comment / Conference, Front Page News /

Conference attendees will enjoy a magical “Evening in the Park” at Disneyland thanks to special support from AveXis, a Novartis company. All registered attendees for the family conference will receive (1) ticket that provides twilight entry to one of the Disneyland parks, when you check-in at registration. On Sunday, June 30th at 4:30pm, all registered

Cure SMA to Host “Evening in the Park” at Disneyland Thanks to Support from AveXis Read More »

Scroll to Top